Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11596-021-2315-4 http://scihub22266oqcxt.onion/10.1007/s11596-021-2315-4 33582903!7881909!33582903     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Med+Sci 2021 ; 41 (1): 39-45 Nephropedia Template TP {{tp|p=33582903|t=2021. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19 |pdf=|usr=}}{{33582903}} gab.com Text Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19 JO: Curr Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33582903 #FOAvip Infection-associated hemophagocytic syndrome (IAHS), a severe complication of various infections, is potentially fatal. This study aims to determine whether IAHS occurs in critically ill patients with coronavirus disease 2019 (COVID-19). We conducted a retrospective observational study on 268 critically ill patients with COVID-19 between February 1st, 2020 and February 26th, 2020. Demographics, clinical characteristics, laboratory results, information on concurrent treatments and outcomes were collected. A diagnosis of secondary hemophagocytic lymphohistiocytosis (sHLH) was made when the patients had an HScore greater than 169. Histopathological examinations were performed to confirm the presence of hemophagocytosis. Of 268 critically ill patients with confirmed SARS-CoV-2 infection, 17 (6.3%) patients had an HScore greater than 169. All the 17 patients with sHLH died. The interval from the onset of symptom of COVID-19 to the time of a diagnosis of sHLH made was 19 days and the interval from the diagnosis of sHLH to death was 4 days. Ten (59%) patients were infected with only SARS-CoV-2. Hemophagocytosis in the spleen and the liver, as well as lymphocyte infiltration in the liver on histopathological examinations, was found in 3 sHLH autopsy patients. Mortality in sHLH patients with COVID-19 is high. And SARS-CoV-2 is a potential trigger for sHLH. Prompt recognition of IAHS in critically ill patients with COVID-19 could be beneficial for improving clinical outcomes. Twit Text FOAVip Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19 ????Curr Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33582903 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33582903 #FOAvip English Wikipedia <ref>{{Cite pmid|33582903}}</ref> Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19 #MMPMID33582903 Yang K; Xing MY; Jiang LY; Cai YP; Yang LL; Xie NN; Chen J; Wang WX; Wang L; Zhu JL; Zhang DY; Ruan QR; Song JX Curr Med Sci 2021[Feb]; 41 (1): 39-45 PMID33582903show ga Infection-associated hemophagocytic syndrome (IAHS), a severe complication of various infections, is potentially fatal. This study aims to determine whether IAHS occurs in critically ill patients with coronavirus disease 2019 (COVID-19). We conducted a retrospective observational study on 268 critically ill patients with COVID-19 between February 1st, 2020 and February 26th, 2020. Demographics, clinical characteristics, laboratory results, information on concurrent treatments and outcomes were collected. A diagnosis of secondary hemophagocytic lymphohistiocytosis (sHLH) was made when the patients had an HScore greater than 169. Histopathological examinations were performed to confirm the presence of hemophagocytosis. Of 268 critically ill patients with confirmed SARS-CoV-2 infection, 17 (6.3%) patients had an HScore greater than 169. All the 17 patients with sHLH died. The interval from the onset of symptom of COVID-19 to the time of a diagnosis of sHLH made was 19 days and the interval from the diagnosis of sHLH to death was 4 days. Ten (59%) patients were infected with only SARS-CoV-2. Hemophagocytosis in the spleen and the liver, as well as lymphocyte infiltration in the liver on histopathological examinations, was found in 3 sHLH autopsy patients. Mortality in sHLH patients with COVID-19 is high. And SARS-CoV-2 is a potential trigger for sHLH. Prompt recognition of IAHS in critically ill patients with COVID-19 could be beneficial for improving clinical outcomes. |Adult[MESH] |Aged[MESH] |COVID-19/*complications/mortality[MESH] |Critical Illness[MESH] |Female[MESH] |Humans[MESH] |Lymphohistiocytosis, Hemophagocytic/etiology/*mortality[MESH] |Male[MESH] |Middle Aged[MESH] |Mortality[MESH] |Prognosis[MESH]Infection-associated Hemophagocytic Syndrome in Critically Ill Patient(epmc).pdf DeepDyve Pubget Overpricing